GS1's Ulrike Kreysa on A Global Outlook to Unique Device Identifiers for Medical Devices

Add bookmark
GS1, received on 17 December, 2013 accreditation by the U.S. Food and Drug Administration (FDA) as issuing agency for unique device identifiers (UDIs).  In this interview, Ulrike Kreysa Vice President of Healthcare for GS1 global office, speaks to Andrea Charles from Pharma IQ about the importance of aligning master data, how the FDA final rule for UDIs is impacting the landscape and what's next for European regulation. Pharma IQ: The FDA final rule for UDIs came out last year. How...
To continue reading this story get free access

Upcoming Events

DigIT Pharma 2026 | AI Commercial, Medical & Patient Care

September 9 - 10, 2026

Steigenberger Airport Hotel Berlin, Deutschland

DigIT Pharma 2026 | AI Commercial, Medical & Patient Care

Pharmaceutical Launch Excellence Summit US

September 30 - October 1, 2026

Hyatt Regency Boston Harbor, Boston, US

Pharmaceutical Launch Excellence Summit US

Pharmaceutical Launch Excellence Summit

1 - 3 December, 2026

Novotel Amsterdam City, Netherlands

Pharmaceutical Launch Excellence Summit

SmartLab Exchange Europe

22 - 23 February 2027

Leonardo Royal Hotel Amsterdam, Netherlands

SmartLab Exchange Europe

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended